Incyte Corporation (INCY)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 834,215 | 529,116 | 570,444 | -232,218 | 486,791 |
Revenue | US$ in thousands | 3,693,100 | 3,394,640 | 2,986,270 | 2,666,700 | 2,158,760 |
Pretax margin | 22.59% | 15.59% | 19.10% | -8.71% | 22.55% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $834,215K ÷ $3,693,100K
= 22.59%
Incyte Corp.'s pretax margin has shown fluctuating trends over the past five years. In 2023, the pretax margin stood at 22.57%, reflecting a significant improvement compared to the previous year when it was 15.59%. This increase indicates better profitability before accounting for taxes in 2023. In 2021, the company also posted a respectable pretax margin of 19.10%, indicating strong operational efficiency.
However, in 2020, Incyte Corp. reported a negative pretax margin of -8.71%, which could be a concerning sign as it indicates that the company's operating expenses exceeded its gross profit before accounting for taxes. The company rebounded strongly in 2019 with a pretax margin of 22.55%, demonstrating robust profitability before tax expenses.
Overall, while Incyte Corp. has displayed varying levels of pretax margin over the past five years, the recent improvement in 2023 is a positive sign for the company's financial performance. Monitoring this metric over time will be crucial to assess the company's ongoing profitability and operational efficiency.
Peer comparison
Dec 31, 2023